BPA Call W91YTZ23A0014-W81K0426FA032
Award Date 12/31/25
Potential Completion Date 12/31/25
Potential Value $11K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fort Meade, MD 20755, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a BPA call valued at $8,279.36 to Cerilliant Corporation, doing business as Cerilliant API Services LLC, on July 30, 2024, with an ultimate completion date of August 1, 2024. This firm fixed-price contract call (FTDTL BPA CALL W91YTZ23A0014) was issued without set-aside designation and will be performed at Fort Meade, Maryland. The award falls under one of Cerilliant's existing Blanket Purchase Agreements with the Defense Health Agency, the primary of which is a...
- The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call valued at $11,104.95 to Cerilliant Corporation for forensic toxicology and drug screening laboratory supplies at Fort Meade, Maryland. The firm fixed-price call was awarded on March 14, 2025, with an ultimate completion date of March 21, 2025. This award was made without a set-aside designation, reflecting Cerilliant's specialized capabilities as a manufacturer of certified reference materials, chemical and biological...
- The Defense Health Agency awarded Cerilliant Corporation a $18,074.80 Blanket Purchase Agreement (BPA) call order on June 1, 2025, for the delivery of forensic toxicology drug testing laboratory supplies to the Forensic Toxicology Drug Testing Laboratory (FTDTL) located at Fort Meade, Maryland. This firm fixed-price call order, with an ultimate completion date of June 8, 2025, was issued without a set-aside designation, reflecting Cerilliant's specialized capabilities in certified reference...
- Cerilliant Corporation was awarded a $19,723.40 firm fixed price blanket purchase agreement call from the Defense Health Agency to provide drug supplies. As a global leader in certified reference standards for over 30 years, Cerilliant will deliver chemical reference materials from its Round Rock, Texas headquarters to support agency testing and healthcare programs at the place of performance in Fort Meade, Maryland. Cerilliant currently holds several indefinite delivery/indefinite quantity...
- The Defense Health Agency awarded Cerilliant Corporation a $37,499.78 firm fixed-price Blanket Purchase Agreement (BPA) call on August 8, 2025, for drug standards to be used in screening and confirmation testing of suspected drug use in service member urine, blood, and tissue samples, both for living personnel and post-mortem analysis. The contract represents a task order against Cerilliant's existing BPA with the Defense Health Agency and carries an ultimate completion date of September 30,...
- The Defense Health Agency awarded a $21,685.45 firm fixed price Blank Purchase Agreement (BPA) call to Cerilliant Corporation for drug standards to be used in screening and analysis testing for suspected drug use in service member blood, urine, and/or tissue testing. This contract, which was not issued under any set-aside designation, leverages Cerilliant's established Indefinite Delivery Vehicle with the Defense Health Agency—a $250,000 BPA for drug reference standards and laboratory supplies...
- Cerilliant Corporation, doing business as Cerilliant API Services LLC, was awarded a Blanket Purchase Agreement (BPA) call valued at $15,522.70 by the Defense Health Agency on August 1, 2024, with an ultimate completion date of August 15, 2024. This Firm Fixed Price contract, designated FTDTL BPA CALL W91YTZ23A0014, will be performed at Fort Meade, Maryland, and involves the supply of certified reference materials and laboratory supplies. The award carries no set-aside designation, reflecting...
- This is a federal contract award to Cerilliant Corporation, a foreign-owned, for-profit manufacturer of chemical and biological reference materials based in Round Rock, Texas. The contract, awarded by the Defense Health Agency (DHA), is for the provision of medical supplies. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type and a ceiling value of $32,348.38. The contract is set to expire on September 30, 2023. Cerilliant Corporation has a history of...
- The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call valued at approximately $42.5K to Cerilliant Corporation for drug standards to be used in screening and confirmation testing of suspected drug use in service member and post-mortem urine, blood, and tissue samples. The contract, awarded on June 18, 2025, with a completion date of September 30, 2025, is structured as a firm fixed-price arrangement with no set-aside designation. Performance will be conducted at...
- This federal contract award to Cerilliant Corporation, a foreign-owned manufacturer based in Round Rock, Texas, is for the supply of drug standards used for screening and confirmation testing of urine, blood, and tissue samples from service members suspected of drug use. The $10,010.88 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call with the Defense Health Agency (DHA), a defense agency. Cerilliant, which has over 30 years of experience as a government contractor, will...